ID
25393
Beschrijving
Phase A - Year 2 Extension - Telephone contact 27 - GSK Study: Evaluation of safety and efficacy of VarilrixTM and of Combined Measles-Mumps-Rubella-Varicella Vaccine NCT00226499 Study ID: 100388 Clinical Study ID: 100388 Study Title: Study in Healthy Children (<2 Years) to Evaluate the Safety and Efficacy of GSK Biologicals' Live Attenuated Varicella Vaccine (VarilrixTM) and of GSK Biologicals' Combined Measles-Mumps-Rubella-Varicella Vaccine Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00226499 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: Varicella Vaccine Trade Name: BIO OKAH; Varilrix Study Indication: Varicella
Trefwoorden
Versies (1)
- 02-09-17 02-09-17 -
Houder van rechten
glaxoSmithKline
Geüploaded op
2 september 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Phase A - Year 2 Extension - Telephone contact 27 - GSK Study: Evaluation of safety and efficacy of VarilrixTM and of Combined Measles-Mumps-Rubella-Varicella Vaccine NCT00226499
Phase A - Year 2 Extension - Telephone contact 27 - GSK Study: Evaluation of safety and efficacy of VarilrixTM and of Combined Measles-Mumps-Rubella-Varicella Vaccine NCT00226499
Beschrijving
Household exposure
Alias
- UMLS CUI-1
- C0332157
- UMLS CUI-2
- C0020052
Beschrijving
Exposure in household to varicella/zoster
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0008049
- UMLS CUI [1,2]
- C0332157
- UMLS CUI [1,3]
- C0020052
- UMLS CUI [2,1]
- C0740380
- UMLS CUI [2,2]
- C0332157
- UMLS CUI [2,3]
- C0020052
Beschrijving
Household exposure number
Alias
- UMLS CUI-1
- C0332157
- UMLS CUI-2
- C0020052
- UMLS CUI-3
- C0449788
Beschrijving
Household Exposure No
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0332157
- UMLS CUI [1,2]
- C0020052
- UMLS CUI [1,3]
- C0449788
Beschrijving
Date of onset exposure
Datatype
date
Alias
- UMLS CUI [1,1]
- C0574845
- UMLS CUI [1,2]
- C0332157
Beschrijving
Type of exposure
Datatype
integer
Alias
- UMLS CUI [1]
- C0332157
Beschrijving
Varicella or zoster
Alias
- UMLS CUI-1
- C0008049
- UMLS CUI-3
- C0740380
Beschrijving
if 'yes', please complete the Varicella or Zoster Case section.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0037088
- UMLS CUI [1,2]
- C0740380
- UMLS CUI [2,1]
- C0037088
- UMLS CUI [2,2]
- C0008049
Beschrijving
Number of episodes of varicella/zoster signs and symptoms
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0037088
- UMLS CUI [1,2]
- C0740380
- UMLS CUI [2,1]
- C0037088
- UMLS CUI [2,2]
- C0008049
Beschrijving
Serious adverse event
Alias
- UMLS CUI-1
- C1519255
Similar models
Phase A - Year 2 Extension - Telephone contact 27 - GSK Study: Evaluation of safety and efficacy of VarilrixTM and of Combined Measles-Mumps-Rubella-Varicella Vaccine NCT00226499
C0681850 (UMLS CUI [1,2])
C0332157 (UMLS CUI [1,2])
C0020052 (UMLS CUI [1,3])
C0740380 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C0020052 (UMLS CUI [2,3])
C0020052 (UMLS CUI-2)
C0449788 (UMLS CUI-3)
C0020052 (UMLS CUI [1,2])
C0449788 (UMLS CUI [1,3])
C0332157 (UMLS CUI [1,2])
C0740380 (UMLS CUI [1,2])
C0037088 (UMLS CUI [2,1])
C0008049 (UMLS CUI [2,2])
C0740380 (UMLS CUI [1,2])
C0037088 (UMLS CUI [2,1])
C0008049 (UMLS CUI [2,2])
Geen commentaren